038290.KQ
Macrogen, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 10,950.00
−2.58%Year over year
Reported trailing growth
- Revenue
- +23.0%
- EBITDA
- -54.1%
- EBIT
- +159.7%
- EPS
- +256.9%
- Free cash flow
- +106.1%
- Operating cash flow
- +367.5%
Forward estimates
Based on analyst estimates
- Revenue
- -24.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.1%
- EBITDA
- +724.5%
- EBIT
- -86.6%
- Net income
- +126.7%
- EPS
- +124.6%
- Free cash flow
- +51.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026